ANA 5 Reflex Test Code Update

ANA 9 Reflex Test Code Update

Clinical Utility of Beta hCG Test Update

Testing Provided on Site for CA 27.29 Antigen

New Regulatory Requirement for CAP 2ID

Methodology Change for Anti-CCP BioPlex

Testing Change for Celiac Disease Evaluation

Clinical Report Format Revision

Reference Range Change for CRP Highly Sensitive

DASSM Test Update

Discontinued: Test Code DASSM

DTex Technical Update

Elevated Serum Total Protein Test Update

Resulting EMR Accounts Update – Glucose LOINC

Resulting EMR Accounts Update – Lipid

Testing Provided on Site for Fecal Immunochemical Testing

Testing Provided on Site for Gliadin, IgA & IgG

Discontinued: Test Code HBSAQ

Testing Provided on Site for Inhibin B

Alert Value Test Update

Discontinuation Notice: PACE 2 Assay for Chlamydia trachomatis and Neisseria gonorrhea

Discontinued: Syphilis Screen IgG w/Reflex to FTA

Testing Provided on Site for Thyroglobulin

Testing Provided on Site for Tissue Transglutaminase IgA

Testing Provided on Site for Urinalysis with Reflex to Culture

Methodology Change for Vitamin D 25- Hydroxy Testing

Celiac Disease Evaluation Interpretive Guide

Morphologic review and interpretation of biopsy material continues to be the backbone of oncology diagnostics, and is the basis on which PathGroup deploys complement technologies to give the clearest, most accurate picture of a patient’s malignancy from original diagnosis to the presence of minimal residual disease.

Every case is managed by a board-certified hematopathologist that works in concert with the ordering physician to understand the patient’s clinical history. That information is then integrated with the results of any testing to provide diagnostic, prognostic and therapeutic guidance for the best patient management and outcome.

As part of this approach PathGroup offers the iPath® Comprehensive Assessment for blood and bone marrow disorders. With one simple order, iPath includes a clinical pathology evaluation, bone marrow and/or blood morphology, flow cytometry, cytogenetics and/or FISH, and PCR as medically necessary to establish a diagnosis or follow disease progression. All findings are then presented in a concise summary report correlating the technologies for easy review.

Our oncology testing menu is built on a core offering that begins with morphologic examination and includes:

• Immunohistohemistry (IHC)
• Flow Cytometry
• Fluorescent In Situ Hybridization (FISH)

• Cytogenetics
• PCR /Molecular Diagnostics

Additionally, PathGroup can provide seamless billing that allows patients to contact us directly and physicians to focus on treatment.

• All insurances accepted; PathGroup maintains preferred provider status with an extensive national, regional and local contracted payer list
• No patient balance billing with the exception of deductibles, co-pays and co-insurance as required by law
• >98% of claims processed as in-network annually; rare out-of-network claims honored as in-network

PathGroup is committed to providing state-of-the-art testing in more than 80,000 square feet of lab space, featuring innovative molecular, anatomic and validation labs to support Phase I−IV clinical trials. Our objective is to become an extension of your study team, collaborating on solutions to reach a common goal: optimized study outcomes.

Leadership and direction are provided by a dedicated BioPharma Services staff to oversee your project from start to finish. Our Quality Management team drives regulatory and risk management efforts for all stakeholders. PathGroup’s Data Management group utilizes the latest in proprietary and industry standard technology to provide custom databases and essential data reporting formats.

• Diversified molecular pathology portfolio with actionable genomic variance data
• NGS testing from single analyte, custom panel development including translocations
• Proprietary extraction method for enhanced DNA/RNA isolation
• Sophisticated bioinformatics suite with integrated solutions including data analysis and customized reporting capabilities

Areas of expertise within PathGroup’s full-service laboratory include:

• Women’s Health
• Dermatology
• Hematology Oncology
• Gastroenterology
• Molecular Oncology
• Urology
• Infectious Diseases
• Non-Gyn Cytopathology
• Inherited Genetics
• Soft Tissue and Bone Pathology
• Pharmacogenomics
• Breast Pathology
• Validation and Development

PathGroup core technologies include:

• Immunohistochemistry (IHC)
• Flow Cytometry
• Cytogenetics
• Fluorescence in Situ Hybridization (FISH)
• Chromogenic in Situ Hybridization (CISH)
• Polymerase Chain Reaction (PCR)
• DNA Sequencing: single analyte to comprehensive industry leading panels
• Array-Based Comparative Genomic Hybridization (CGA)
• High-Sensitivity and Specialty Assays

In keeping with PathGroup’s commitment to excellence in pathology, we are CAP accredited and CLIA certified.

Contact us to schedule time to discuss your project:

biopharma@pathgroup.com
615-221-4455

MyResults Patient Results Portal

The MyResults Patient Results Portal is an online portal where patients can access all PathGroup performed lab results conveniently through their computer, smartphone, or tablet. With a username and password they choose, patients can log in to see results for laboratory testing performed by PathGroup. In addition to lab results, patients can explore “Get Smart” education materials where they can learn more about the tests ordered and the impact on their overall health.

Patients can sign up to access their completed lab results online at the MyResults Patient Portal. Test results will be available in the portal once they are finalized in the laboratory. Patients will receive an email notifying them when results are available in the portal.

CLICK HERE to create a MyResults Patient Results Portal account or to access your results.

If you need assistance with accessing results, patients can CLICK HERE to complete a form to request assistance.

MyResults Patient Results Portal and the Apple® Health App

The PathGroup MyResults Patient Results Portal is now integrated with the Apple Health app. This allows iPhone users to see their PathGroup laboratory test results directly within the Health app using Health Records. Downloaded health records data is stored on-device and encrypted with the user’s iPhone passcode, Touch ID or Face ID.

To add your PathGroup MyResults Patient Portal Account to Apple® Health:

1. Open the Health app.
2. Tap “Browse” at the bottom of the screen.
3. Scroll to the “Health Records” section at the bottom of the screen, and tap “Add an Account”.
4. Search for PathGroup, then tap it.
5. Under Available To Connect, tap “Connect to Account”.
6. Sign in to your MyResults Patient Portal account or create a new one.
7. Wait for your records to update. It might take a minute for your information to appear.

Additional information about how to use the Health app is available at support.apple.com. Click here for the Setup Guide.

MyResultsPAP

Now your patients can retrieve their Pap test results quickly and easily, at their convenience. Our MyResults messaging service gives your patient access to their Pap test results quickly and conveniently, 24 hours a day. The system is secured and helps PathGroup’s clients control costs by eliminating negative Pap mailers and postage expenses.

For additional information regarding MyResultsPAP, please contact your local PathGroup representative.